Search research articles
Contact Us
Filters
Showing results (61-70 of 82) with videos related to
Page
of 9
Sort By:
Prostate Cancer and Prostatic Diseases
|
August 20, 2021
Correction: Protective effect of pharmacological castration on metabolic perturbations and cardiovascular disease in the hyperglycemic male ApoE<sup>-/-</sup>:Ins2<sup>+/Akita</sup> mouse model
Wilhelmina C M Duivenvoorden, Magda Naeim, Sarah N Hopmans, et al.
Prostate Cancer and Prostatic Diseases
|
September 29, 2020
Protective effect of pharmacological castration on metabolic perturbations and cardiovascular disease in the hyperglycemic male ApoE<sup>-/-</sup>:Ins2<sup>+/Akita</sup> mouse model
Wilhelmina C M Duivenvoorden, Magda Naeim, Sarah N Hopmans, et al.
Clinical Proteomics
|
February 12, 2013
Quantitative proteomic analysis of amniocytes reveals potentially dysregulated molecular networks in Down syndrome
Chan-Kyung J Cho, Andrei P Drabovich, George S Karagiannis, et al.
Journal of Kidney Cancer and VHL
|
January 5, 2024
Intraoperative Embolization during Inferior Vena Cava Tumor Thrombectomy for Renal Cell Carcinoma
Samantha A Roberts, Divyaam Satija, Henry Gold, et al.
Journal of Patient Experience
|
August 22, 2025
Assessment of Patient Experience During Active Surveillance for Prostate Cancer
Devon M Langston, Matthew J DePuccio, Ann Scheck McAlearney, et al.
Cancers
|
January 8, 2025
Role of Neoadjuvant Immunotherapy in Genitourinary Malignancies
Adam Khorasanchi, Karan Jatwani, Lingbin Meng, et al.
Clinical Genitourinary Cancer
|
November 30, 2024
Impact of Preoperative Systemic Therapy on Cytoreductive Nephrectomy Outcomes in the National Surgical Quality Improvement Program (NSQIP)
Shawn Dason, Rajvi Goradia, Victor Heh, et al.
Frontiers in Oncology
|
August 14, 2023
Salvage lenvatinib/everolimus combination therapy after immune checkpoint inhibitor and VEGFR tyrosine kinase inhibitor for metastatic renal cell carcinoma
Christopher Kwok, Adam Khorasanchi, Sarah P Psutka, et al.
The Journal of Urology
|
April 8, 2020
Late Recurrences Following Radical Cystectomy Have Distinct Prognostic and Management Considerations
Shawn Dason, Eugene K Cha, Cristina Falavolti, et al.
Prostate Cancer
|
January 19, 2026
Change in Clinical Management of Localized Prostate Cancer Patients at a Tertiary Medical Center as a Result of SARS-CoV-2 (COVID-19)
Alexander Yaney, Jonathan E Schoenhals, Yevgeniya Gokun, et al.
Page
of 9
Search research articles
Search
Showing results (61-70 of 82) with videos related to
Sort By:
Page
of 9
Prostate Cancer and Prostatic Diseases
|
August 20, 2021
Correction: Protective effect of pharmacological castration on metabolic perturbations and cardiovascular disease in the hyperglycemic male ApoE<sup>-/-</sup>:Ins2<sup>+/Akita</sup> mouse model
Wilhelmina C M Duivenvoorden, Magda Naeim, Sarah N Hopmans, et al.
Prostate Cancer and Prostatic Diseases
|
September 29, 2020
Protective effect of pharmacological castration on metabolic perturbations and cardiovascular disease in the hyperglycemic male ApoE<sup>-/-</sup>:Ins2<sup>+/Akita</sup> mouse model
Wilhelmina C M Duivenvoorden, Magda Naeim, Sarah N Hopmans, et al.
Clinical Proteomics
|
February 12, 2013
Quantitative proteomic analysis of amniocytes reveals potentially dysregulated molecular networks in Down syndrome
Chan-Kyung J Cho, Andrei P Drabovich, George S Karagiannis, et al.
Journal of Kidney Cancer and VHL
|
January 5, 2024
Intraoperative Embolization during Inferior Vena Cava Tumor Thrombectomy for Renal Cell Carcinoma
Samantha A Roberts, Divyaam Satija, Henry Gold, et al.
Journal of Patient Experience
|
August 22, 2025
Assessment of Patient Experience During Active Surveillance for Prostate Cancer
Devon M Langston, Matthew J DePuccio, Ann Scheck McAlearney, et al.
Cancers
|
January 8, 2025
Role of Neoadjuvant Immunotherapy in Genitourinary Malignancies
Adam Khorasanchi, Karan Jatwani, Lingbin Meng, et al.
Clinical Genitourinary Cancer
|
November 30, 2024
Impact of Preoperative Systemic Therapy on Cytoreductive Nephrectomy Outcomes in the National Surgical Quality Improvement Program (NSQIP)
Shawn Dason, Rajvi Goradia, Victor Heh, et al.
Frontiers in Oncology
|
August 14, 2023
Salvage lenvatinib/everolimus combination therapy after immune checkpoint inhibitor and VEGFR tyrosine kinase inhibitor for metastatic renal cell carcinoma
Christopher Kwok, Adam Khorasanchi, Sarah P Psutka, et al.
The Journal of Urology
|
April 8, 2020
Late Recurrences Following Radical Cystectomy Have Distinct Prognostic and Management Considerations
Shawn Dason, Eugene K Cha, Cristina Falavolti, et al.
Prostate Cancer
|
January 19, 2026
Change in Clinical Management of Localized Prostate Cancer Patients at a Tertiary Medical Center as a Result of SARS-CoV-2 (COVID-19)
Alexander Yaney, Jonathan E Schoenhals, Yevgeniya Gokun, et al.
Page
of 9